Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Wallace

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Medical Physics|February 24, 2001
Empirical dosimetric characterization of model I125-SL 125iodine brachytherapy source in phantomR E Wallace
Medical Physics|December 10, 1999
Dosimetric characterization of a new design 103 palladium brachytherapy sourceR E Wallace, J J Fan
Medical Physics|November 26, 1998
Evaluation of a new brachytherapy iodine-125 source by AAPM TG43 formalismR E Wallace, J J Fan
Medical Physics|December 1, 2000
Fitting and benchmarking of dosimetry data for new brachytherapy sourcesE E Furhang, R E Wallace
Mutation Research|November 1, 1994
Mutational spectrum of revertants in the hisD3052 allele of Salmonella typhimurium induced by hydrogen peroxide-activated benzidineR E Wallace, P D Josephy
Cancer Chemotherapy and Pharmacology|January 1, 1989
Arabinofuranosyl-5-azacytosine: activity against human tumors in athymic miceR E Wallace, D Lindh, F E Durr
Cancer Investigation|January 1, 1987
Development of resistance and characteristics of a human colon carcinoma subline resistant to mitoxantrone in vitroR E Wallace, D Lindh, F E Durr
Applied and Environmental Microbiology|February 1, 1995
Mineralization of mono- and dichlorobenzenes and simultaneous degradation of chloro- and methyl-substituted benzenes by the white rot fungus Phanerochaete chrysosporiumJ S Yadav, R E Wallace, C A Reddy
Cancer Treatment Reviews|December 1, 1983
Molecular and biochemical pharmacology of mitoxantroneF E Durr, R E Wallace, R V Citarella
Medical Physics|May 8, 2001
Comparison of I-125 sources used for permanent interstitial implantsB H Heintz, R E Wallace, J M Hevezi
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Medical Physics|February 24, 2001
Empirical dosimetric characterization of model I125-SL 125iodine brachytherapy source in phantomR E Wallace
Medical Physics|December 10, 1999
Dosimetric characterization of a new design 103 palladium brachytherapy sourceR E Wallace, J J Fan
Medical Physics|November 26, 1998
Evaluation of a new brachytherapy iodine-125 source by AAPM TG43 formalismR E Wallace, J J Fan
Medical Physics|December 1, 2000
Fitting and benchmarking of dosimetry data for new brachytherapy sourcesE E Furhang, R E Wallace
Mutation Research|November 1, 1994
Mutational spectrum of revertants in the hisD3052 allele of Salmonella typhimurium induced by hydrogen peroxide-activated benzidineR E Wallace, P D Josephy
Cancer Chemotherapy and Pharmacology|January 1, 1989
Arabinofuranosyl-5-azacytosine: activity against human tumors in athymic miceR E Wallace, D Lindh, F E Durr
Cancer Investigation|January 1, 1987
Development of resistance and characteristics of a human colon carcinoma subline resistant to mitoxantrone in vitroR E Wallace, D Lindh, F E Durr
Applied and Environmental Microbiology|February 1, 1995
Mineralization of mono- and dichlorobenzenes and simultaneous degradation of chloro- and methyl-substituted benzenes by the white rot fungus Phanerochaete chrysosporiumJ S Yadav, R E Wallace, C A Reddy
Cancer Treatment Reviews|December 1, 1983
Molecular and biochemical pharmacology of mitoxantroneF E Durr, R E Wallace, R V Citarella
Medical Physics|May 8, 2001
Comparison of I-125 sources used for permanent interstitial implantsB H Heintz, R E Wallace, J M Hevezi
Pageof 3